Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Vonoprazan in Adolescents With Symptomatic Gastroesophageal Reflux Disease [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the pharmacokinetics, pharmacodynamics, and safety of vonoprazan in adolescents with symptomatic gastroesophageal reflux disease has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Vonoprazan (vonoprazan)

Snippet

Sponsor: Phathom Pharmaceuticals, Inc. | Conditions: Gastroesophageal Reflux | Phase 1 | Status: COMPLETED | Results posted: 2024-06-03